My Quote Request
6505-00-958-8974
20 Products
NDC00062-5420-77
VAGINAL JELLY,ANTIS
NSN, MFG P/N
6505009588974
NSN
6505-00-958-8974
MFG
ORTHO PHARMACEUTICAL CORP OMNI EDUCATION DIV SUB OF JOHNSON AND JOHNSON
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: CONTAINING ACETIC ACID 0.92 PCT,OXYQUINOLINE SULFATE 0.025 PCT,RICINOLEIC ACID 0.7 PCT,BORIC ACID 3 PCT AND GLYCERIN 5 PCT,85 GM TUBE W/MEASURED-DOSE APPLICATOR,QTY UNIT OF PKG 12'S
Related Searches:
ELASE
FIBRINOLYSIN AND DESOXYRIBONUCLEASE,COMBINED (BOVINE),OINTMENT
NSN, MFG P/N
6505009588975
NSN
6505-00-958-8975
ELASE
FIBRINOLYSIN AND DESOXYRIBONUCLEASE,COMBINED (BOVINE),OINTMENT
NSN, MFG P/N
6505009588975
NSN
6505-00-958-8975
MFG
ASTELLAS PHARMA US INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FIBRINOLYSIN & DESOXYRIBONUCLEASE COMBINED (BOVINE) OINTMENT 30GM
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
SPECIAL FEATURES: SHALL CONTAIN PER 30 GRAMS: 30 UNIT FIBRINOLYSIN,20,000 UNITS DESOXYRIBONUCLEASE,AND 0.12 MG THIMERUSOL IN AN OINTMENT BASE OF LIQUID PETROLATUM AND POLYETHYLENE; COLLAPSIBLE OINTMENT TUBE
Related Searches:
NDC00469-7004-30
FIBRINOLYSIN AND DESOXYRIBONUCLEASE,COMBINED (BOVINE),OINTMENT
NSN, MFG P/N
6505009588975
NSN
6505-00-958-8975
NDC00469-7004-30
FIBRINOLYSIN AND DESOXYRIBONUCLEASE,COMBINED (BOVINE),OINTMENT
NSN, MFG P/N
6505009588975
NSN
6505-00-958-8975
MFG
ASTELLAS PHARMA US INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FIBRINOLYSIN & DESOXYRIBONUCLEASE COMBINED (BOVINE) OINTMENT 30GM
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
SPECIAL FEATURES: SHALL CONTAIN PER 30 GRAMS: 30 UNIT FIBRINOLYSIN,20,000 UNITS DESOXYRIBONUCLEASE,AND 0.12 MG THIMERUSOL IN AN OINTMENT BASE OF LIQUID PETROLATUM AND POLYETHYLENE; COLLAPSIBLE OINTMENT TUBE
Related Searches:
NDC57317-0013-77
FIBRINOLYSIN AND DESOXYRIBONUCLEASE,COMBINED (BOVINE),OINTMENT
NSN, MFG P/N
6505009588975
NSN
6505-00-958-8975
NDC57317-0013-77
FIBRINOLYSIN AND DESOXYRIBONUCLEASE,COMBINED (BOVINE),OINTMENT
NSN, MFG P/N
6505009588975
NSN
6505-00-958-8975
MFG
ASTELLAS PHARMA US INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FIBRINOLYSIN & DESOXYRIBONUCLEASE COMBINED (BOVINE) OINTMENT 30GM
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
SPECIAL FEATURES: SHALL CONTAIN PER 30 GRAMS: 30 UNIT FIBRINOLYSIN,20,000 UNITS DESOXYRIBONUCLEASE,AND 0.12 MG THIMERUSOL IN AN OINTMENT BASE OF LIQUID PETROLATUM AND POLYETHYLENE; COLLAPSIBLE OINTMENT TUBE
Related Searches:
ESIDRIX
HYDROCHLOROTHIAZIDE TABLETS,USP
NSN, MFG P/N
6505009589056
NSN
6505-00-958-9056
ESIDRIX
HYDROCHLOROTHIAZIDE TABLETS,USP
NSN, MFG P/N
6505009589056
NSN
6505-00-958-9056
MFG
CIBA-GEIGY CORP CIBA PHARMACEUTICALS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS HYDROCHLOROTHIAZIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
DEPO-TESTOSTERONE
TESTOSTERONE CYPIONATE INJECTION,USP
NSN, MFG P/N
6505009589186
NSN
6505-00-958-9186
DEPO-TESTOSTERONE
TESTOSTERONE CYPIONATE INJECTION,USP
NSN, MFG P/N
6505009589186
NSN
6505-00-958-9186
MFG
PFIZER PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS TESTOSTERONE CYPIONATE PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TESTOSTERONE CYPIONATE INJECTION USP 200MG/ML 10ML VIAL
III PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
PHARMACEUTICAL VEHICLE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: MULTIPLE-DOSE VIAL; CLASS 3
Related Searches:
NDC00009-0417-02
TESTOSTERONE CYPIONATE INJECTION,USP
NSN, MFG P/N
6505009589186
NSN
6505-00-958-9186
NDC00009-0417-02
TESTOSTERONE CYPIONATE INJECTION,USP
NSN, MFG P/N
6505009589186
NSN
6505-00-958-9186
MFG
PFIZER PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS TESTOSTERONE CYPIONATE PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TESTOSTERONE CYPIONATE INJECTION USP 200MG/ML 10ML VIAL
III PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
PHARMACEUTICAL VEHICLE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: MULTIPLE-DOSE VIAL; CLASS 3
Related Searches:
NDC00058-0705-05
ATROPINE SULFATE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505009593566
NSN
6505-00-959-3566
NDC00058-0705-05
ATROPINE SULFATE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505009593566
NSN
6505-00-959-3566
MFG
COOPER LABORATORIES INC COOPER VISION PHARMACEUTICALS INC DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, W/V ATROPINE SULFATE ACTIVE INGREDIENT
ADMINISTRATION: TOPICAL
FEATURES PROVIDED: STERILE
PHARMACEUTICAL VEHICLE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
STINGKILL
TRIETHANOLAMINE AND BENZALKONIUM CHLORIDE SOLUTION
NSN, MFG P/N
6505009593739
NSN
6505-00-959-3739
STINGKILL
TRIETHANOLAMINE AND BENZALKONIUM CHLORIDE SOLUTION
NSN, MFG P/N
6505009593739
NSN
6505-00-959-3739
MFG
NORTH HEALTH CARE A DIV OF SIEBE NORTH INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, W/V BENZALKONIUM CHLORIDE ACTIVE INGREDIENT AND 30.000 PERCENTAGE, W/V TRIETHANOLAMINE ACTIVE INGREDIENT
ADMINISTRATION: TOPICAL
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 0.500 MILLILITERS
PRIMARY CONTAINER TYPE: SWABS
TOTAL PRIMARY CONTAINER QUANTITY: 144
Related Searches:
ADRENALIN
EPINEPHRINE NASAL SOLUTION,USP
NSN, MFG P/N
6505009594263
NSN
6505-00-959-4263
ADRENALIN
EPINEPHRINE NASAL SOLUTION,USP
NSN, MFG P/N
6505009594263
NSN
6505-00-959-4263
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 UNITS EPINEPHRINE PER MILLILITER
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00182-1225-01
ASPIRIN AND CODEINE PHOSPHATE TABLETS,USP
NSN, MFG P/N
6505009594331
NSN
6505-00-959-4331
NDC00182-1225-01
ASPIRIN AND CODEINE PHOSPHATE TABLETS,USP
NSN, MFG P/N
6505009594331
NSN
6505-00-959-4331
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 325.000 MILLIGRAMS ASPIRIN ACTIVE INGREDIENT AND 30.000 MILLIGRAMS CODEINE PHOSPHATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
SPECIAL FEATURES: CONTROLLED SUBSTANCE CLASSIFICATION:SCHEDULE III
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,BURROUGHS WELLCOME CO
Related Searches:
ELECTR0LYTEN048
ELECTROLYTE SOLUTIO
NSN, MFG P/N
6505009594483
NSN
6505-00-959-4483
MFG
BAXTER HEALTHCARE CORP
Description
DESIGN CONTROL REFERENCE: ELECTR0LYTEN048
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 500 CC,UNIT QTY,BOTTLE
MANUFACTURERS CODE: 06204
REFERENCE NUMBER DIFFERENTIATING CHARACTERISTICS: 5 PCT DEXTROSE
THE MANUFACTURERS DATA:
Related Searches:
ELECTR0LYTEN048
ELECTROLYTE SOLUTIO
NSN, MFG P/N
6505009594485
NSN
6505-00-959-4485
MFG
CUTTER LABORATORIES INC
Description
DESIGN CONTROL REFERENCE: ELECTR0LYTEN048
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 250 CC,UNIT QTY,BOTTLE
MANUFACTURERS CODE: 93702
REFERENCE NUMBER DIFFERENTIATING CHARACTERISTICS: 5 PCT DEXTROSE
THE MANUFACTURERS DATA:
Related Searches:
PR0NESTYL
PROCAINAMIDE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505009596139
NSN
6505-00-959-6139
PR0NESTYL
PROCAINAMIDE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505009596139
NSN
6505-00-959-6139
MFG
SQUIBB E R AND SONS INC WORLD HQ
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS PROCAINAMIDE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 120.000
CAPSULE TYPE: HARD
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
1114
POTASSIUM PERMANGANATE TABLETS FOR SOLUTION
NSN, MFG P/N
6505009596147
NSN
6505-00-959-6147
1114
POTASSIUM PERMANGANATE TABLETS FOR SOLUTION
NSN, MFG P/N
6505009596147
NSN
6505-00-959-6147
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 65.000 MILLIGRAMS POTASSIUM PERMANGANATE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ADMINISTRATION:ORAL NONCHEWABLE;
Related Searches:
970
POTASSIUM PERMANGANATE TABLETS FOR SOLUTION
NSN, MFG P/N
6505009596147
NSN
6505-00-959-6147
970
POTASSIUM PERMANGANATE TABLETS FOR SOLUTION
NSN, MFG P/N
6505009596147
NSN
6505-00-959-6147
MFG
ROBINSON LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 65.000 MILLIGRAMS POTASSIUM PERMANGANATE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ADMINISTRATION:ORAL NONCHEWABLE;
Related Searches:
171-10
FLUOROURACIL INJECTION,USP
NSN, MFG P/N
6505009608383
NSN
6505-00-960-8383
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS FLUOROURACIL PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FLOUROURACIL INJECTION USP 50MG/ML 10ML VIAL 10 VIALS PG
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00004-1977-01
FLUOROURACIL INJECTION,USP
NSN, MFG P/N
6505009608383
NSN
6505-00-960-8383
NDC00004-1977-01
FLUOROURACIL INJECTION,USP
NSN, MFG P/N
6505009608383
NSN
6505-00-960-8383
MFG
HOFFMANN-LA ROCHE INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS FLUOROURACIL PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FLOUROURACIL INJECTION USP 50MG/ML 10ML VIAL 10 VIALS PG
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00013-1036-95
FLUOROURACIL INJECTION,USP
NSN, MFG P/N
6505009608383
NSN
6505-00-960-8383
NDC00013-1036-95
FLUOROURACIL INJECTION,USP
NSN, MFG P/N
6505009608383
NSN
6505-00-960-8383
MFG
ERBAMONT INC ADRIA LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS FLUOROURACIL PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FLOUROURACIL INJECTION USP 50MG/ML 10ML VIAL 10 VIALS PG
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00469-1710-30
FLUOROURACIL INJECTION,USP
NSN, MFG P/N
6505009608383
NSN
6505-00-960-8383
NDC00469-1710-30
FLUOROURACIL INJECTION,USP
NSN, MFG P/N
6505009608383
NSN
6505-00-960-8383
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS FLUOROURACIL PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FLOUROURACIL INJECTION USP 50MG/ML 10ML VIAL 10 VIALS PG
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10